Fig. 9: Biosafety evaluation of different treatments. | Nature Communications

Fig. 9: Biosafety evaluation of different treatments.

From: Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors

Fig. 9

a H&E staining histology of heart, spleen and lung to evaluate the safety of different treatments. Scale bars, 100 μm. Data were pooled from three independent experiments. b The body weight of mice monitored during the therapy (n = 6 mice). c Systemic cytotoxicity evaluation of different treatments (n = 5 mice). ALT, serum alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen. Data are presented as mean ± s.d. Error bars represent s.d. Source data of (b) and (c) are provided as a Source Data file.

Back to article page